Salute e Benessere

Theriva™ Biologics to Host Conference Call and Webcast to Discuss Full Year 2023…

Individuals may participate in the live call via telephone by dialing 1-877-451-6152 (domestic) or 1-201-389-0879 (international) and using the conference ID: 13744453. Participants are asked to dial-in 15 minutes before the start of the call to register. Investors and the public can access the live and archived webcast of this call via the “News & Media” section of the company's website,https://www.therivabio.com, under “Events” or by clickinghere, up to 90 days after the call...
Nasdaq GlobeNewswire
19/03/2024

Cover the Latest Developments in Allergy and Clinical Immunology at the EAACI…

https://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, Spain, March19, 2024(GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI), with a membership of over 16,000 from 125 countries, annually orchestrates its congress to unveil the latest research and innovative advancements in allergy and clinical immunology. We are thrilled to extend a warm invitation to you for the upcoming EAACI Congress 2024, scheduled to...
Nasdaq GlobeNewswire
19/03/2024

Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™…

The proprietary AI-Immunology™ platform brings the potential for a new era in vaccine discovery, design and development using advanced AI and machine learning technologiesAI-Immunology™ outcompetes standard vaccine target discovery approaches and holds the promise of addressing serious unmet needsWith a unique modular architecture, AI-Immunology™ is scalable and adaptable towards partner needsThe potential of AI-Immunology™ is validated by established partnerships, including an ongoing...
Nasdaq GlobeNewswire
19/03/2024

SPEVIGO® approved for expanded indications in China and the US

Generalized pustular psoriasis (GPP) is a rare, chronic, heterogenous neutrophilic inflammatory disease associated with skin and systemic symptoms, such as fever, pain, and fatigue 1,2,3,4 In China, SPEVIGO ® 's expanded approval adds the reduction of occurrences of GPP in pediatric patients aged 12 and above weighing ≥40 kg, and adults 5 The US FDA's approval expands the use of SPEVIGO ® to include the treatment of GPP in adults and pediatric patients aged 12 and above weighing ≥40 kg,...
Nasdaq GlobeNewswire
19/03/2024

Samsung Medison and Bracco Imaging Forge Path with New Diagnostic Ultrasound…

The aim of this MoU is to create synergy in research and development and market exploration by combining the techniques and marketing capabilities of Samsung Medison, one of the world's leading manufacturers of innovative premium ultrasound diagnostic equipment, and Bracco Imaging, an innovative global leader delivering end-to-end products and solutions through a comprehensive portfolio inclusive of precision diagnostic imaging modalities. The aim of this MoU is to create synergy in research...
PR Newswire
19/03/2024

Telum Therapeutics appoints Dr. Subhendu Basu as CEO

"I am truly inspired by Telum's cutting-edge science, its dynamic pipeline, and the team's accomplishments thus far," remarked Dr. Basu. "As CEO, I am eager to collaborate with the Telum scientific team and our dedicated investors to spur growth and advance Telum's investigational products into clinical trials for patient benefit." "I am truly inspired by Telum's cutting-edge science, its dynamic pipeline, and the team's accomplishments thus far," remarked Dr. Basu…
PR Newswire
19/03/2024

Leading in health technology innovation: Philips one of the top patent…

March 19, 2024 Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is one of the leading patent applicants at the European Patent Office (EPO). Building on more than 130 years of innovation, Philips' extensive global R&D programs and collaborations position the company at the forefront of health technology innovation. In 2023, Philips improved the health and well-being of 1.9 billion people with its...
Nasdaq GlobeNewswire
19/03/2024

LifeSpan Vision Ventures Invests in SENISCA

The proceeds of SENISCA's largest fundraise to date will support continued rapid company evolution and the preclinical development of the Company's senotherapeutic programmes, that target the causes of age-related disease via RNA splicing regulation, resulting in cellular reprogramming and disease modification by attenuating senescence. The proceeds of SENISCA's largest fundraise to date will support continued rapid company evolution and the preclinical development of the Company's...
PR Newswire
19/03/2024

PharmaVentures acts as the exclusive M&A advisor on the successful sale of…

Adrian Dawkes, Managing Director at PharmaVentures, said: "We are delighted to have leveraged our network and capabilities in M&A to deliver this successful outcome for Phasefocus shareholders. It is particularly pleasing to help this innovative UK technology company gain commercial validation from Bruker, a global player in the imaging, material and life science research sector." Fintan Walton, Chairman and Chief Executive at PharmaVentures added: "This transaction endorses…
PR Newswire
19/03/2024

SmartCella AB appoints Oskar Steneryd as new CFO

Niklas Prager, CEO of SmartCella, says: "It's a great pleasure to announce that Oskar is joining SmartCella. He has a stellar track record from investing in businesses in the biotech and life science space, a strong commercial focus, and a wealth of experience from financial leadership and reporting. He will be instrumental in building our Finance and Business Control function further as SmartCella is entering the next phase of expansion and market visibility. Having a CFO who combines…
PR Newswire
19/03/2024

Tetra Pharm Technologies introduces pain relieving drug in the United Kingdom

XATEPA® is a carefully formulated drug designed to provide effective relief from chronic pain as well as discomfort arising from MS spasms and nausea. The innovative sublingual spray is devised as an enabling technology to provide optimal conditions for cannabinoid uptake and efficacy. XATEPA® is a carefully formulated drug designed to provide effective relief from chronic pain as well as discomfort arising from MS spasms and nausea. The innovative sublingual spray is devised as an enabling...
PR Newswire
19/03/2024

Electrolux Group publishes restated figures for the new business area structure

From the interim report for the first quarter of 2024, Electrolux Group will be reporting in accordance with the new business area structure. From the interim report for the first quarter of 2024, Electrolux Group will be reporting in accordance with the new business area structure. The appendix to this press release contains selected restated figures by business area, by quarter and for full year 2022 and 2023. The restated financial information can also be found on the Group's website:...
PR Newswire
19/03/2024

BioArctic: Professor Lars Lannfelt, awarded Fondation Recherche Alzheimer's…

"Being able to give hope and contribute to the treatment of patients affected by Alzheimer's disease is what has driven me throughout my research life," said Professor Lars Lannfelt. "It is inspiring to see how research in this field has now begun to take quantum leaps with the development of treatments such as lecanemab which demonstrated meaningful benefits to patients in the global Phase 3 Clarity AD trial using gold standard endpoints. Coupled with the introduction of modern…
PR Newswire
19/03/2024

Implantica wins another RefluxStop™ public tender in Europe, this time in Spain…

Dr. Ruiz de Adana adds, "Our patients who had the RefluxStop™ procedure report that they no longer have episodes of gastric reflux and experienced no side effects such as dysphagia almost one year after surgery. We also see no adverse events related to RefluxStop™ so far." He goes on to say, "With sustained outcomes, RefluxStop™ has the potential to become the new standard of care for patients with severe GERD." Dr. Ruiz de Adana adds, "Our patients who had the…
PR Newswire
19/03/2024

Mendus to present NK cell program progress at the Innate Killer Summit

Press Release Stockholm, Sweden, March 19, 2024Mendus AB ("Mendus" publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, announces that it will present the progress of its NK cell program at the 9th Annual Innate Killer Cell Summit, a leading conference for NK cell-based therapies.Mendus Director of Research Satwinder Kaur Singh, PhD will be expert speaker at the 9 thAnnual Innate Killer Summit held March 18-20 in San Diego, CA, USA...
Nasdaq GlobeNewswire
19/03/2024

ObsEva Announces Update on Board of Directors

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 18, 2024– ObsEva SA (SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women's health, today announced that, concurrent to the decision to wind-down the company's operations, Catarina Edfjäll, Ph.D. has decided to step down from the Board effective today.“We would like to warmly thank Catarina for her significant contribution to the company over...
Nasdaq GlobeNewswire
19/03/2024

IBA signs contract to install a Be-Efficient irradiation solution in Germany

Louvain-la-Neuve, Belgium, March 19, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial irradiation, announced today it has signed a contract for the installation of a Be-Efficient electron beam irradiation solution equipped with two Rhodotron ®accelerators in Germany. This Be-Efficient electron beam solution includes two Rhodotron ®accelerators, a Beagle® production line...
Nasdaq GlobeNewswire
19/03/2024

AstriVax Rounds Out Executive Team with Chief Business Officer (CBO) Dr. Gregory…

Dr. Fanning brings a wealth of experience in creating infectious disease pipelines by internal R&D and licensing As the CBO of AstriVax, he will lead the company's business development, including partnerships, collaborations and non dilutive funding to drive the pipeline forward and create value for future funding rounds. His initial focus will be on the company's candidate vaccine to treat chronic Hepatitis B and shape the future AstriVax vaccine pipeline.Leuven, Belgium, March...
Nasdaq GlobeNewswire
19/03/2024

Alma launches a special edition of Soprano Titanium with a breakthrough…

Engineered for efficiency and speed, the special edition of the award-winning world-leading hair removal platform leverages the benefits of three synergistic wavelengths to take the concept of speed to a whole new level with superior results: SHR, a clinically-proven, virtually painless method of laser hair removal enables effective and comfortable treatments for all skin types, 3D simultaneous lasing of the three most effective laser wavelengths for hair removal (755nm, 810nm, and 1064nm), and…
PR Newswire
19/03/2024

MCE 2024 Milan: Midea RAC Unveils Sustainable Solutions for Cooling, Heating…

Having achieved a remarkable global sales milestone of over 6.2 million units, Midea leads the charge in promoting their advanced R290 products, demonstrating an unwavering dedication to sustainability. At this exhibition, Midea introduced its R290 Combo product lineup and R290 multi-split research project for the first time. Midea has always been exploring the technical difficulties of the R290 one drive three multi-split system and has made initial progress in the refrigerant leakage sensor…
PR Newswire
19/03/2024

TELUS Mental Health Index: Alarming isolation and loneliness levels among young…

The World Health Organization (WHO) has declared loneliness to be a pressing global threat, with the effects of isolation and loneliness now being recognized and compared to well-known health risks such as smoking, obesity and lack of physical activity. In fact, the US surgeon general is saying that its mortality effects are equivalent to smoking 15 cigarettes a day. The World Health Organization (WHO) has declared loneliness to be a pressing global threat, with the effects of isolation...
PR Newswire
19/03/2024

Inventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept…

LEGEND achieved its primary efficacy endpoint by significantly lowering HbA1c level in both the lanifibranor arm and in the lanifibranor with empagliflozin arm compared to placebo.Statistical significance was also achieved on several markers of liver injury, markers of glucose and lipid metabolism, as well as hepatic steatosis.Patients treated with lanifibranor in combination with empagliflozin maintained a stable weight throughout the 24 weeks study, addressing the moderate,...
Nasdaq GlobeNewswire
18/03/2024

Near Infrared Imaging Market Projected to Reach $3.60 billion by 2030 -…

Near Infrared Imaging (NIRI) is transforming the landscape of non-invasive diagnostics with its capability to utilize wavelengths between 700 and 2500 nanometers, providing deep insights into biological tissues. The technology's enhancement, driven by breakthroughs in detector sensitivity and sophisticated image analysis algorithms, is revolutionizing healthcare through improved image quality. The global rise in surgical procedures demanding minimally invasive diagnostics further leads to a…
PR Newswire
18/03/2024

New Purina study reveals 73% of pet owners view their pet as a best friend

The bond between pets and owners doesn't just include daily activities. When it comes to a family holiday, 48 per cent of pet owners take their pets with them. 4 per cent of these even make sure to take their pet abroad. The bond between pets and owners doesn't just include daily activities. When it comes to a family holiday, 48 per cent of pet owners take their pets with them. 4 per cent of these even make sure to take their pet abroad. Claire Robinson-Davies also said, "Pet owners are...
PR Newswire
18/03/2024
Altri  Comunicati